StockData
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. (SNOA) stock

SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3082% below fair value
$0.83−0.01 (-0.76%)

Close on Nov 18, 2026Market cap $3.96MP/E –Yield –

Sonoma Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Sonoma Pharmaceuticals's price to book ratio was 0.9× on Nov 11, 2026, against 1.5× a year earlier. Over the last 5 years it ranged from 0.1× to 1.8×, with a median of 0.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×−0.7
2025Dec 31, 20251.6×+0.9
2024Dec 31, 20240.7×+0.5
2023Dec 29, 20230.2×−0.3
2022Dec 30, 20220.5×−0.7
2021Dec 31, 20211.2×−0.1
2020Dec 31, 20201.3×+0.7
2019Dec 31, 20190.6×+0.1
2018Dec 31, 20180.4×−1.0
2017Dec 29, 20171.5×−2.1
2016Dec 30, 20163.5×+1.8
2015Dec 31, 20151.8×+0.8
2014Dec 31, 20140.9×−14.0
2013Dec 31, 201314.9×−64.1
2012Oct 31, 201279.0×−30.2
2011Oct 31, 2011109.2×–

More Sonoma Pharmaceuticals figures

See a number that looks wrong?